Research Progress on Berberine Regulating the NLRP3 Inflammasome, Gut Microbiota and Intestinal Epithelial Barrier to Improve Inflammatory Bowel Disease
Berberine (BBR) is a natural alkaloid with multi-target pharmacological activity. In recent years its potential therapeutic value in inflammatory bowel disease (IBD) has received wide attention. To sort out systematically the pharmacological mechanisms by which BBR improves IBD, this study searched PubMed, Web of Science and CNKI for the literature from 2015 to 2025, focusing on basic research, systematic reviews, meta-analyses and clinical studies, and analyzed three mechanistic axes, the NLRP3 inflammasome, the gut microbiota and the intestinal epithelial barrier. The interaction among the three drew our attention. Current evidence shows that BBR can inhibit the NF-κB/NLRP3 signaling pathway and related pyroptosis, thereby reducing intestinal inflammatory response; it can also reshape gut microbiota structure, promote the recovery of beneficial bacteria and regulate microbial metabolites; in addition, BBR can upregulate tight junction protein expression, promote epithelial regeneration and mucosal repair, and thereby improve intestinal epithelial barrier function. The three axes are not independent of each other but interrelated and mutually reinforcing, forming a synergistic network centered on inflammation inhibition, microbiota recovery and barrier repair. At the clinical level, preliminary evidence from ulcerative colitis (UC) suggests that BBR combined with 5-aminosalicylic acid (5-ASA) may have some adjunctive therapeutic value, but high-quality, large-sample, multicenter randomized controlled trials (RCTs) are still insufficient. In general, BBR shows multi-target pharmacological action in IBD treatment, but its clinical efficacy and long-term safety still need further verification.
Authors
- Shengyu Huang
Institutions
- Peking University (CN)
Publication Details
- Journal
- Theoretical and Natural Science
- Published
- 2026-11-17
- DOI
- https://doi.org/10.54254/2753-8818/2026.es39048
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 0.00